Clinical trial
Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma: a Phase 3 Non-inferior Multicenter Randomized Controlled Trial
NCT02610010 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma: a Phase 3 Non-inferior Multicenter Randomized Controlled Trial
- Lead sponsor
- Sun Yat-sen University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- November 30, 2015
- Completion date
- November 30, 2025
- Enrollment
- 462 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.